When this recognition occurs against MiHA expressed by the leukemic cells, donor T cells induce graft-versus-leukemia (GVL) processes; however, if the polymorphic peptide is also expressed in normal cells, undesirable graft-versus-host disease (GVHD) can also occur [46]. The gene discussed is XIAP; the disease is graft versus host disease.